Item 1. Financial Statements
Item 1. Financial Statements
FORMFACTOR, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited)
July 1,
2023 December 31,
2022
ASSETS
Current assets:
Cash and cash equivalents $ 97,981 $ 109,130
Marketable securities 138,943 129,006
Accounts receivable, net of allowance for credit losses of $ 510 and $ 168
94,013 88,143
Inventories, net 120,298 123,157
Restricted cash 1,144 1,221
Prepaid expenses and other current assets 25,876 23,895
Total current assets 478,255 474,552
Restricted cash 2,265 2,631
Operating lease, right-of-use-assets 31,001 31,362
Property, plant and equipment, net of accumulated depreciation 204,577 189,848
Goodwill 211,929 211,444
Intangibles, net 22,149 26,751
Deferred tax assets 71,172 67,646
Other assets 3,790 3,994
Total assets $ 1,025,138 $ 1,008,228
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 63,770 $ 69,308
Accrued liabilities 31,413 42,115
Current portion of term loan, net of unamortized issuance costs 1,150 1,045
Deferred revenue 19,899 29,846
Operating lease liabilities 7,871 7,353
Total current liabilities 124,103 149,667
Term loan, less current portion, net of unamortized issuance costs 13,765 14,389
Deferred tax liabilities 2,704 2,732
Long-term operating lease liabilities 26,458 27,587
Deferred grant 18,000 —
Other liabilities 5,845 5,568
Total liabilities 190,875 199,943
Stockholders’ equity:
Common stock, $ 0.001 par value:
250,000,000 shares authorized; 77,184,012 and 76,914,590 shares issued and outstanding
77 77
Additional paid-in capital 867,517 844,842
Accumulated other comprehensive loss ( 4,445 ) ( 5,578 )
Accumulated deficit ( 28,886 ) ( 31,056 )
Total stockholders’ equity 834,263 808,285
Total liabilities and stockholders’ equity $ 1,025,138 $ 1,008,228
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended Six Months Ended
July 1,
2023 June 25,
2022 July 1,
2023 June 25,
2022
Revenues $ 155,916 $ 203,907 $ 323,364 $ 401,081
Cost of revenues 95,633 109,538 202,003 212,488
Gross profit 60,283 94,369 121,361 188,593
Operating expenses:
Research and development 28,340 28,317 56,585 55,451
Selling, general and administrative 33,255 33,406 65,997 66,312
Total operating expenses 61,595 61,723 122,582 121,763
Operating income (loss) ( 1,312 ) 32,646 ( 1,221 ) 66,830
Interest income, net 1,482 181 2,758 127
Other income, net 450 551 473 743
Income before income taxes 620 33,378 2,010 67,700
Provision (benefit) for income taxes ( 208 ) 3,136 ( 160 ) 7,586
Net income $ 828 $ 30,242 $ 2,170 $ 60,114
Net income per share:
Basic $ 0.01 $ 0.39 $ 0.03 $ 0.77
Diluted $ 0.01 $ 0.38 $ 0.03 $ 0.76
Weighted-average number of shares used in per share calculations:
Basic 77,159 77,897 77,112 78,071
Diluted 77,616 79,210 77,450 79,423
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
(Unaudited)
Three Months Ended Six Months Ended
July 1,
2023 June 25,
2022 July 1,
2023 June 25,
2022
Net income $ 828 $ 30,242 $ 2,170 $ 60,114
Other comprehensive income (loss), net of tax:
Translation adjustments ( 122 ) ( 3,856 ) 710 ( 6,554 )
Unrealized gains (losses) on available-for-sale marketable securities ( 85 ) ( 547 ) 518 ( 1,751 )
Unrealized gains (losses) on derivative instruments ( 52 ) ( 116 ) ( 95 ) 758
Other comprehensive income (loss), net of tax: ( 259 ) ( 4,519 ) 1,133 ( 7,547 )
Comprehensive income $ 569 $ 25,723 $ 3,303 $ 52,567
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(In thousands, except shares)
(Unaudited)
Shares of
Common
Stock Common
Stock Additional
Paid-in
Capital Accumulated
Other
Comprehensive
Loss Accumulated
Deficit Total
Six Months Ended July 1, 2023
Balances, December 31, 2022 76,914,590 $ 77 $ 844,842 $ ( 5,578 ) $ ( 31,056 ) $ 808,285
Issuance of common stock under the Employee Stock Purchase Plan 210,055 — 5,024 — — 5,024
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax 59,367 — ( 456 ) — — ( 456 )
Stock-based compensation — — 18,107 — — 18,107
Other comprehensive income — — — 1,133 — 1,133
Net income — — — — 2,170 2,170
Balances, July 1, 2023 77,184,012 $ 77 $ 867,517 $ ( 4,445 ) $ ( 28,886 ) $ 834,263
Three Months Ended July 1, 2023
Balances, April 1, 2023 77,142,023 $ 77 $ 858,195 $ ( 4,186 ) $ ( 29,714 ) $ 824,372
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax 41,989 — ( 69 ) — — ( 69 )
Stock-based compensation — — 9,391 — — 9,391
Other comprehensive loss — — — ( 259 ) — ( 259 )
Net income — — — — 828 828
Balances, July 1, 2023 77,184,012 $ 77 $ 867,517 $ ( 4,445 ) $ ( 28,886 ) $ 834,263
Six Months Ended June 25, 2022
Balances, December 25, 2021 78,240,506 $ 78 $ 898,945 $ ( 1,449 ) $ ( 81,794 ) $ 815,780
Issuance of common stock under the Employee Stock Purchase Plan 157,642 — 5,645 — — 5,645
Issuance of common stock pursuant to exercise of options 6,000 — 42 — — 42
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax 234,076 — ( 4,243 ) — — ( 4,243 )
Purchase and retirement of common stock through repurchase program ( 1,443,491 ) ( 1 ) ( 54,327 ) — — ( 54,328 )
Stock-based compensation — — 14,522 — — 14,522
Other comprehensive loss — — — ( 7,547 ) — ( 7,547 )
Net income — — — — 60,114 60,114
Balances, June 25, 2022 77,194,733 $ 77 $ 860,584 $ ( 8,996 ) $ ( 21,680 ) $ 829,985
Three Months Ended June 25, 2022
Balances, March 26, 2022 78,166,212 $ 78 $ 902,994 $ ( 4,477 ) $ ( 51,922 ) $ 846,673
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax 231,464 — ( 4,171 ) — — ( 4,171 )
Purchase and retirement of common stock through repurchase program ( 1,202,943 ) ( 1 ) ( 44,930 ) — — ( 44,931 )
Stock-based compensation — — 6,691 — — 6,691
Other comprehensive loss — — — ( 4,519 ) — ( 4,519 )
Net income — — — — 30,242 30,242
Balances, June 25, 2022 77,194,733 $ 77 $ 860,584 $ ( 8,996 ) $ ( 21,680 ) $ 829,985
The accompanying notes are an integral part of these condensed consolidated financial statements.
6
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Six Months Ended
July 1,
2023 June 25,
2022
Cash flows from operating activities:
Net income $ 2,170 $ 60,114
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation 15,121 14,146
Amortization 4,766 4,702
Reduction in the carrying amount of right-of-use assets 3,914 4,414
Stock-based compensation expense 18,494 13,878
Deferred income tax benefit ( 3,639 ) ( 3,703 )
Provision for excess and obsolete inventories 8,628 4,726
Other adjustments to reconcile net income to net cash provided by operating activities 1,801 3,846
Changes in assets and liabilities:
Accounts receivable ( 6,830 ) 5,530
Inventories ( 5,880 ) ( 32,268 )
Prepaid expenses and other current assets ( 1,099 ) 1,295
Other assets ( 83 ) ( 40 )
Accounts payable 3,578 7,521
Accrued liabilities ( 10,606 ) 4,102
Other liabilities 456 73
Deferred revenues ( 9,945 ) 2,727
Deferred grant 18,000 —
Operating lease liabilities ( 4,065 ) ( 4,262 )
Net cash provided by operating activities 34,781 86,801
Cash flows from investing activities:
Acquisition of property, plant and equipment ( 40,177 ) ( 30,116 )
Acquisition of business — ( 3,121 )
Purchases of marketable securities ( 66,650 ) ( 52,344 )
Purchase of promissory note receivable — ( 1,000 )
Proceeds from maturities and sales of marketable securities 58,363 45,470
Net cash used in investing activities ( 48,464 ) ( 41,111 )
Cash flows from financing activities:
Proceeds from issuances of common stock 5,024 5,687
Purchase of common stock through stock repurchase program — ( 54,328 )
Tax withholdings related to net share settlements of equity awards ( 456 ) ( 4,243 )
Principal repayments on term loans ( 519 ) ( 4,379 )
Net cash provided by (used in) financing activities 4,049 ( 57,263 )
Effect of exchange rate changes on cash, cash equivalents and restricted cash ( 1,958 ) ( 3,470 )
Net decrease in cash, cash equivalents and restricted cash ( 11,592 ) ( 15,043 )
Cash, cash equivalents and restricted cash, beginning of period 112,982 155,342
Cash, cash equivalents and restricted cash, end of period $ 101,390 $ 140,299
The accompanying notes are an integral part of these condensed consolidated financial statements.
7
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Six Months Ended
July 1,
2023 June 25,
2022
Non-cash investing and financing activities:
Decrease in accounts payable and accrued liabilities related to property, plant and equipment purchases $ 9,187 $ 4,165
Operating lease, right-of-use assets obtained in exchange for lease obligations 3,635 3,438
Supplemental disclosure of cash flow information:
Cash paid for income taxes, net $ 9,427 $ 6,473
Cash paid for interest 212 294
Operating cash outflows from operating leases 4,514 4,379
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents $ 97,981 $ 136,395
Restricted cash, current 1,144 2,102
Restricted cash, non-current 2,265 1,802
Total cash, cash equivalents and restricted cash $ 101,390 $ 140,299
The accompanying notes are an integral part of these condensed consolidated financial statements.
8
FORMFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1 — Basis of Presentation and Significant Accounting Policies
Basis of Presentation
The accompanying condensed consolidated financial information of FormFactor, Inc. is unaudited and has been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). However, such information reflects all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in our 2022 Annual Report on Form 10-K filed with the SEC on February 24, 2023. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year.
Fiscal Year
We operate on a 52/53 week fiscal year, whereby the fiscal year ends on the last Saturday of December. Fiscal 2023 and 2022 contain 52 weeks and 53 weeks, respectively, and the six months ended July 1, 2023 and June 25, 2022 each contained 26 weeks. Fiscal 2023 will end on December 30, 2023.
Significant Accounting Policies
Our significant accounting policies have not changed during the six months ended July 1, 2023 from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022, except for:
Government Assistance
In January 2023, we received $ 18.0 million in cash from a California Competes Grant (the “Grant”) awarded from the California Governor’s Office of Business and Economic Development. The Grant requires FormFactor to create and maintain full-time jobs and make significant infrastructure investments within California over a 5-year term. If we do not meet the requirements of the Grant, we will be required to repay all or a portion of the Grant.
The Grant is included in our Condensed Consolidated Balance Sheets within Deferred grant and we have elected to recognize the Grant when earned as an offset to Cost of revenues and Operating expenses within our Condensed Consolidated Statements of Income. We have elected to present the proceeds from the Grant as cash provided by operating activities within our Condensed Consolidated Statements of Cash Flows as the Grant is to offset operations.
New Accounting Pronouncements
Reference Rate Reform
In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides temporary optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (“LIBOR“) or another reference rate expected to be discontinued. In December 2022, the FASB issued ASU 2022-06, “Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848,” extending the relief offered in Topic 848 from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the optional expedients in Topic 848.
In May 2023, the Company entered into a rate replacement amendment to its credit facility loan agreement to replace LIBOR with the Secured Overnight Financing Rate (“SOFR”) and concurrently signed an amendment to modify the floating rate option on its interest rate swap to match that of the debt. The Company applied practical expedients provided in Topic 848 allowing the modified instrument to be accounted for and presented in the same manner as the instrument existing before the modification. These modifications had no significant impact on our financial statements. Refer to Note 6, Debt for further information regarding the terms of the credit facility loan agreement and interest rate swap agreement.
Reclassifications
Certain immaterial reclassifications were made to the prior year financial statements to conform to the current year presentation.
9
Note 2 — Concentration of Credit and Other Risks
The following customer accounted for 10 % or more of our revenues for the periods indicated:
Three Months Ended Six Months Ended
July 1,
2023 June 25,
2022 July 1,
2023 June 25,
2022
Intel Corporation 14.2 % 20.9 % 17.2 % 20.9 %
At July 1, 2023 and December 31, 2022, one customer accounted for 15.3 % and 13.8 % of gross accounts receivable, respectively.
Note 3 — Inventories, net
Inventories are stated at the lower of cost (principally standard cost, which approximates actual cost on a first in, first out basis) or net realizable value.
Inventories, net, consisted of the following (in thousands):
July 1,
2023 December 31,
2022
Raw materials $ 55,491 $ 55,726
Work-in-progress 44,549 46,067
Finished goods 20,258 21,364
$ 120,298 $ 123,157
Note 4 — Goodwill and Intangible Assets
Goodwill by reportable segment was as follows (in thousands):
Probe Cards Systems Total
Goodwill, as of December 25, 2021 $ 178,424 $ 33,875 $ 212,299
Addition - Woburn Acquisition — 550 550
Foreign currency translation — ( 1,405 ) ( 1,405 )
Goodwill, as of December 31, 2022 178,424 33,020 211,444
Foreign currency translation — 485 485
Goodwill, as of July 1, 2023 $ 178,424 $ 33,505 $ 211,929
We have no t recorded goodwill impairments for the six months ended July 1, 2023.
Intangible assets were as follows (in thousands):
July 1, 2023 December 31, 2022
Intangible Assets Gross Accumulated
Amortization Net Gross Accumulated
Amortization Net
Existing developed technologies $ 171,896 $ 153,200 $ 18,696 $ 171,441 $ 151,212 $ 20,229
Customer relationships 51,036 48,085 2,951 50,912 45,003 5,909
Trade name 8,000 7,898 102 7,972 7,759 213
In-process research and development 400 — 400 400 — 400
$ 231,332 $ 209,183 $ 22,149 $ 230,725 $ 203,974 $ 26,751
10
Amortization expense was included in our Condensed Consolidated Statements of Income as follows (in thousands):
Three Months Ended Six Months Ended
July 1,
2023 June 25,
2022 July 1,
2023 June 25,
2022
Cost of revenues $ 838 $ 788 $ 1,669 $ 1,596
Selling, general and administrative 1,550 1,545 3,097 3,106
$ 2,388 $ 2,333 $ 4,766 $ 4,702
The estimated future amortization of definite-lived intangible assets, excluding in-process research and development, is as follows (in thousands):
Fiscal Year Amount
Remainder of 2023 $ 2,435
2024 4,624
2025 4,280
2026 3,184
2027 2,839
Thereafter 4,387
$ 21,749
Note 5 — Accrued Liabilities
Accrued liabilities consisted of the following (in thousands):
July 1,
2023 December 31,
2022
Accrued compensation and benefits $ 17,386 $ 15,864
Employee stock purchase plan contributions withheld 4,142 4,585
Accrued income and other taxes 3,944 12,817
Accrued warranty 3,506 4,199
Accrued restructuring charges 207 1,249
Other accrued expenses 2,228 3,401
$ 31,413 $ 42,115
Note 6 — Debt
On June 22, 2020, we entered into an $ 18.0 million 15-year credit facility loan agreement (the “Building Term Loan”) with MUFG Union Bank, National Association (“Union Bank”). The proceeds of the Building Term Loan were used to purchase a building adjacent to our leased facilities in Livermore, California. On May 19, 2023, we amended the Building Term Loan, replacing the benchmark reference rate LIBOR with the term SOFR, with no change to the amount or timing of contractual cash flows.
The Building Term Loan bears interest at a rate equal to the applicable SOFR rate, plus 0.1148 %, plus 1.75 % per annum. Interest payments are payable in monthly installments over a fifteen-year period. The interest rate at July 1, 2023 was 5.17 %.
On March 17, 2020, we entered into an interest rate swap agreement with Union Bank to hedge the interest payment on the Building Term Loan for the notional amount of $ 18.0 million. As future levels of LIBOR over the life of the loan were uncertain, we entered into this interest-rate swap agreement to hedge the exposure in interest rate risks associated with movement in LIBOR rates. By entering into the agreement, we converted a floating-rate interest at one-month LIBOR plus 1.75 % into a fixed-rate interest at 2.75 %. This agreement was amended on May 19, 2023 to replace the benchmark reference rate LIBOR with the term SOFR to match the Building Term Loan agreement (as amended). After the amendment, the interest rate swap continues to convert our floating-rate interest into a fixed-rate at 2.75 %.
11
Note 7 — Restructuring Charges
2022 Restructuring Plan
On October 25, 2022, we adopted a restructuring plan (“2022 restructuring plan”) to align our cost structure with reduced demand levels, by streamlining and improving the efficiency and business effectiveness of our operations. This plan included lowering headcount by approximately 13 % of our workforce.
The Company has recognized 2022 restructuring plan charges of approximately $ 8.1 million for severance and employee-related costs, including $ 0.3 million for stock-based compensation, with $ 7.1 million within the Probe Cards segment, $ 0.5 million within the Systems segment, and $ 0.5 million within Corporate. We do not expect to incur additional material costs related to the 2022 restructuring plan.
2021 Restructuring Plan
On September 25, 2021, we adopted restructuring plans (“2021 restructuring plans”) to improve our business effectiveness and streamline our operations by consolidating certain manufacturing facilities for both the Probe Cards segment and the Systems segment. This included plans to consolidate or relocate certain leased locations in the United States to other locations in the United States, Germany and Asia. As a result of these changes to certain work locations, we have incurred personnel related costs to sever, relocate, or retain select employees. Additionally, as part of these plans we have undertaken actions to adjust capacity for certain product offerings, which included contract termination costs to satisfy contract obligations.
The Company has recognized 2021 restructuring plans charges of approximately $ 13.3 million, with $ 10.1 million within the Probe Cards segment and $ 3.2 million within the Systems segment, which were comprised of $ 1.4 million of severance and employee-related costs, $ 2.0 million in contract and lease termination costs, $ 9.4 million in inventory impairments and other inventory related costs, and $ 0.5 million of cost related to impairment of leasehold improvements, facility exits and fixed asset related costs. We do not expect additional material costs related to the 2021 restructuring plan.
Total restructuring charges for both the 2022 and 2021 restructuring plans included in our Condensed Consolidated Statements of Income were as follows (in thousands):
Three Months Ended
July 1, 2023 June 25, 2022
Probe Cards Systems Total Probe Cards Systems Total
Cost of revenues $ 47 $ 285 $ 332 $ 227 $ 227 $ 454
Research and development 170 51 221 — 53 53
Selling, general and administrative 6 59 65 — 74 74
$ 223 $ 395 $ 618 $ 227 $ 354 $ 581
Six Months Ended
July 1, 2023 June 25, 2022
Probe Cards Systems Total Probe Cards Systems Total
Cost of revenues $ 106 $ 251 $ 357 $ 266 $ 327 $ 593
Research and development 182 109 291 — 199 199
Selling, general and administrative 1,069 118 1,187 3 99 102
$ 1,357 $ 478 $ 1,835 $ 269 $ 625 $ 894
12
Changes to the restructuring accrual in the six months ended July 1, 2023 were as follows (in thousands):
Employee Severance
and Benefits Stock-based Compensation Inventory
Impairments &
Other Inventory
Related Costs Contract
Termination &
Other Costs Total
December 31, 2022 $ 1,249 $ — $ — $ — $ 1,249
Restructuring charges 917 295 390 233 1,835
Cash payments ( 1,959 ) — ( 89 ) ( 233 ) ( 2,281 )
Non-cash settlement — ( 295 ) ( 301 ) — ( 596 )
July 1, 2023 $ 207 $ — $ — $ — $ 207
Note 8 — Fair Value and Derivative Instruments
Whenever possible, the fair values of our financial assets and liabilities are determined using quoted market prices of identical securities or quoted market prices of similar securities from active markets. The three levels of inputs that may be used to measure fair value are as follows:
• Level 1 valuations are obtained from real-time quotes for transactions in active exchange markets involving identical securities;
• Level 2 valuations utilize significant observable inputs, such as quoted prices for similar assets or liabilities, quoted prices near the reporting date in markets that are less active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
• Level 3 valuations utilize unobservable inputs to the valuation methodology and include our own data about assumptions market participants would use in pricing the asset or liability based on the best information available under the circumstances.
We did not have any transfers of assets or liabilities measured at fair value on a recurring basis to or from Level 1, Level 2 or Level 3 during the three and six months ended July 1, 2023 or the year ended December 31, 2022.
The carrying values of Cash, Accounts receivable, net, Restricted cash, Prepaid expenses and other current assets, Accounts payable, and Accrued liabilities approximate fair value due to their short maturities.
No changes were made to our valuation techniques during the first six months of fiscal 2023.
13
Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):
July 1, 2023 Level 1 Level 2 Level 3 Total
Assets:
Cash equivalents:
Money market funds $ 30,179 $ — $ — $ 30,179
U.S. treasuries 1,691 — — 1,691
31,870 — — 31,870
Marketable securities:
U.S. treasuries 46,803 — — 46,803
Certificates of deposit — 235 — 235
U.S. agency securities — 14,733 — 14,733
Corporate bonds — 53,097 — 53,097
Commercial paper — 24,075 — 24,075
46,803 92,140 — 138,943
Foreign exchange derivative contracts — 549 — 549
Promissory note receivable — — 926 926
Interest rate swap derivative contracts — 2,263 — 2,263
Total assets $ 78,673 $ 94,952 $ 926 $ 174,551
Liabilities:
Foreign exchange derivative contracts $ — $ ( 60 ) $ — $ ( 60 )
Total liabilities $ — $ ( 60 ) $ — $ ( 60 )
December 31, 2022 Level 1 Level 2 Level 3 Total
Assets:
Cash equivalents:
Money market funds $ 21,279 $ — $ — $ 21,279
Commercial paper — 4,969 — 4,969
U.S. agency securities — 996 — 996
21,279 5,965 — 27,244
Marketable securities:
U.S. treasuries 25,019 — — 25,019
Certificates of deposit — 706 — 706
U.S. agency securities — 11,045 — 11,045
Corporate bonds — 67,396 — 67,396
Commercial paper — 24,840 — 24,840
25,019 103,987 — 129,006
Foreign exchange derivative contracts — 664 — 664
Promissory note receivable — — 943 943
Interest rate swap derivative contracts — 2,374 — 2,374
Total assets $ 46,298 $ 112,990 $ 943 $ 160,231
Liabilities:
Foreign exchange derivative contracts $ — $ ( 193 ) $ — $ ( 193 )
Total liabilities $ — $ ( 193 ) $ — $ ( 193 )
Cash Equivalents
The fair value of our cash equivalents is determined based on quoted market prices for similar or identical securities.
Marketable Securities
We classify our marketable securities as available-for-sale and value them utilizing a market approach. Our investments are
14
priced by pricing vendors who provide observable inputs for their pricing without applying significant judgment. Broker pricing is used mainly when a quoted price is not available, the investment is not priced by our pricing vendors or when a broker price is more reflective of fair value. Our broker-priced investments are categorized as Level 2 investments because fair value is based on similar assets without applying significant judgments. In addition, all investments have a sufficient trading volume to demonstrate that the fair value is appropriate.
Unrealized gains and losses were immaterial and were recorded as a component of Accumulated other comprehensive loss in our Condensed Consolidated Balance Sheets. We did not have any other-than-temporary unrealized gains or losses at either period end included in these financial statements.
Interest Rate Swaps
The fair value of our interest rate swap contracts is determined at the end of each reporting period based on valuation models that use interest rate yield curves as inputs. For accounting purposes, our interest rate swap contracts qualify for, and are designated as, cash flow hedges. The cash flows associated with the interest rate swaps are reported in Net cash provided by operating activities in our Condensed Consolidated Statements of Cash Flows and the fair value of the interest rate swap contracts are recorded within Prepaid expenses and other current assets and Other assets in our Condensed Consolidated Balance Sheets.
Foreign Exchange Derivative Contracts
We operate and sell our products in various global markets. As a result, we are exposed to changes in foreign currency exchange rates. We utilize foreign currency forward contracts to hedge against future movements in foreign exchange rates that affect certain existing foreign currency denominated assets and liabilities and forecasted foreign currency revenue and expense transactions. Under this program, our strategy is to have increases or decreases in our foreign currency exposures mitigated by gains or losses on the foreign currency forward contracts in order to mitigate the risks and volatility associated with foreign currency transaction gains or losses.
We do not use derivative financial instruments for speculative or trading purposes. For accounting purposes, certain of our foreign currency forward contracts are not designated as hedging instruments and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our Condensed Consolidated Balance Sheets with changes in fair value recorded within Other income, net in our Condensed Consolidated Statement of Income for both realized and unrealized gains and losses. Certain of our foreign currency forward contracts are designated as cash flow hedges, and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our Condensed Consolidated Balance Sheets with changes in fair value recorded as a component of Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings, and in the same line item on the Condensed Consolidated Statements of Income as the impact of the hedge transaction.
The fair value of our foreign exchange derivative contracts was determined based on current foreign currency exchange rates and forward points. All of our foreign exchange derivative contracts outstanding at July 1, 2023 will mature by the second quarter of fiscal 2024.
The following table provides information about our foreign currency forward contracts outstanding as of July 1, 2023 (in thousands):
Currency Contract Position Contract Amount
(Local Currency) Contract Amount
(U.S. Dollars)
Euro Dollar Buy 18,558 $ 19,903
Euro Dollar Sell 1,077 1,176
Japanese Yen Sell 3,104,537 21,583
Korean Won Buy 1,258,185 962
Taiwan Dollar Sell 31,197 1,001
Our foreign currency contracts are classified within Level 2 of the fair value hierarchy as they are valued using pricing models that utilize observable market inputs.
Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis
We measure and report our non-financial assets such as Property, plant and equipment, Goodwill and Intangible assets at fair value on a non-recurring basis if we determine these assets to be impaired or in the period when we make a business
15
acquisition. Other than as discussed in Note 7, Restructuring Charges, there were no assets or liabilities measured at fair value on a nonrecurring basis during the three and six months ended July 1, 2023 or June 25, 2022.
Note 9 — Warranty
We offer warranties on certain products and record a liability for the estimated future costs associated with warranty claims at the time revenue is recognized. The warranty liability is based upon historical experience and our estimate of the level of future costs. While we engage in product quality programs and processes, our warranty obligation is affected by product failure rates, material usage and service delivery costs. We regularly monitor product returns for warranty and maintain a reserve for the related expenses based upon our historical experience and any specifically identified failures. As we sell new products to our customers, we must exercise considerable judgment in estimating the expected failure rates. This estimating process is based on historical experience of similar products, as well as various other assumptions that we believe to be reasonable under the circumstances. We provide for the estimated cost of product warranties at the time revenue is recognized as a component of Cost of revenues in our Condensed Consolidated Statement of Income.
Changes in our warranty liability were as follows (in thousands):
Six Months Ended
July 1,
2023 June 25,
2022
Balance at beginning of period $ 4,199 $ 2,805
Accruals 2,934 3,846
Settlements ( 3,627 ) ( 2,673 )
Balance at end of period $ 3,506 $ 3,978
Note 10 — Property, Plant and Equipment, net
Property, plant and equipment, net consisted of the following (in thousands):
July 1,
2023 December 31,
2022
Land $ 17,136 $ 17,136
Building and building improvements 44,452 44,932
Machinery and equipment 284,837 276,180
Computer equipment and software 46,774 45,813
Furniture and fixtures 7,468 7,540
Leasehold improvements 88,416 86,500
Sub-total 489,083 478,101
Less: Accumulated depreciation and amortization ( 349,123 ) ( 335,711 )
Net, property, plant and equipment 139,960 142,390
Construction-in-process 64,617 47,458
Total $ 204,577 $ 189,848
Note 11 — Stockholders’ Equity and Stock-Based Compensation
Common Stock Repurchase Programs
On October 26, 2020, our Board of Directors authorized a two-year program to repurchase up to $ 50 million of outstanding common stock to offset potential dilution from issuances of common stock under our stock-based compensation programs. During the six months ended June 25, 2022, we repurchased 676,408 shares of common stock for $ 26.0 million. We utilized the remaining funds available for repurchase under this program during fiscal 2022.
On May 20, 2022, our Board of Directors authorized an additional program to repurchase up to $ 75 million of outstanding common stock, also with the primary purpose to offset potential dilution from issuances of common stock under our stock-based compensation programs. The share repurchase program will expire on May 20, 2024. During the six months ended July 1, 2023, we did no t repurchase any common stock. As of July 1, 2023, $ 18.6 million remained available for future repurchases.
16
Our policy related to repurchases of our common stock is to charge the excess of cost over par value to additional paid-in capital once the shares are retired. All repurchases were made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended.
Restricted Stock Units
Restricted stock unit (“RSU”) activity under our equity incentive plan was as follows:
Units Weighted Average Grant Date Fair Value
RSUs at December 31, 2022 2,227,081 $ 35.28
Awards granted 1,014,619 30.97
Awards vested ( 75,144 ) 37.76
Awards forfeited ( 122,881 ) 35.09
RSUs at July 1, 2023 3,043,675 33.78
Performance Restricted Stock Units
We may grant Performance RSUs (“PRSUs”) to certain executives, which vest based upon us achieving certain market performance criteria. There were no market based PRSUs granted during the six months ended July 1, 2023. PRSUs are included as part of the RSU activity above.
Employee Stock Purchase Plan
Information related to activity under our Employee Stock Purchase Plan (“ESPP”) was as follows:
Six Months Ended
July 1, 2023
Shares issued 210,055
Weighted average per share purchase price $ 23.92
Weighted average per share discount from the fair value of our common stock on the date of issuance $ ( 4.22 )
Stock-Based Compensation
Stock-based compensation was included in our Condensed Consolidated Statements of Income as follows (in thousands):
Three Months Ended Six Months Ended
July 1,
2023 June 25,
2022 July 1,
2023 June 25,
2022
Cost of revenues $ 1,515 $ 734 $ 3,425 $ 1,812
Research and development 2,363 1,695 4,735 3,681
Selling, general and administrative 5,326 3,929 10,334 8,385
Total stock-based compensation $ 9,204 $ 6,358 $ 18,494 $ 13,878
Unrecognized Compensation Costs
At July 1, 2023, the unrecognized stock-based compensation was as follows (dollars in thousands):
Unrecognized Expense Average Expected
Recognition Period
in Years
Restricted stock units $ 60,794 2.28
Performance restricted stock units 7,789 1.72
Employee stock purchase plan 246 0.09
Total unrecognized stock-based compensation expense $ 68,829 2.22
17
Note 12 — Net Income per Share
The following table reconciles the shares used in calculating basic net income per share and diluted net income per share (in thousands):
Three Months Ended Six Months Ended
July 1,
2023 June 25,
2022 July 1,
2023 June 25,
2022
Weighted-average shares used in computing basic net income per share 77,159 77,897 77,112 78,071
Add potentially dilutive securities 457 1,313 338 1,352
Weighted-average shares used in computing diluted net income per share 77,616 79,210 77,450 79,423
Securities not included as they would have been antidilutive 486 23 343 —
Note 13 — Commitments and Contingencies
Leases
See Note 14, Leases .
Contractual Obligations and Commitments
Our contractual obligations and commitments have not materially changed as of July 1, 2023 from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.
Legal Matters
From time to time, we are subject to legal proceedings and claims in the ordinary course of business, the outcomes of which cannot be estimated with certainty. Our ability to estimate the outcomes may change in the near term and the effect of any such change could have a material adverse effect on our financial position, results of operations or cash flows.
Note 14 — Leases
We lease real estate space under non-cancelable operating lease agreements for commercial and industrial space, as well as for a portion of our corporate headquarters located in Livermore, California. Our leases have remaining terms of 1 to 6 years, and some leases include options to extend up to 20 years. We also have operating leases for automobiles with remaining lease terms of 1 year. We did not include any of our renewal options in our lease terms for calculating our lease liability as the renewal options allow us to maintain operational flexibility and we are not reasonably certain we will exercise these options at this time. The weighted-average remaining lease term for our operating leases was 5 years as of July 1, 2023 and the weighted-average discount rate was 4.28 %.
The components of lease expense were as follows (in thousands):
Three Months Ended Six Months Ended
July 1,
2023 June 25,
2022 July 1,
2023 June 25,
2022
Lease expense:
Operating lease expense $ 2,124 $ 2,183 $ 4,076 $ 4,404
Short-term lease expense 136 76 293 116
Variable lease expense 483 677 1,229 1,135
$ 2,743 $ 2,936 $ 5,598 $ 5,655
18
Future minimum payments under our non-cancelable operating leases were as follows as of July 1, 2023 (in thousands):
Fiscal Year Amount
Remainder of 2023 $ 4,295
2024 8,667
2025 8,575
2026 7,049
2027 6,631
Thereafter 3,434
Total minimum lease payments 38,651
Less: interest ( 4,322 )
Present value of net minimum lease payments 34,329
Less: current portion ( 7,871 )
Total long-term operating lease liabilities $ 26,458
Note 15 — Revenue
Transaction price allocated to the remaining performance obligations: On July 1, 2023, we had $ 9.4 million of remaining performance obligations, which were comprised of deferred service contracts and extended warranty contracts and contracts with overtime revenue recognition that are not yet delivered. We expect to recognize approximately 46.7 % of our remaining performance obligations as revenue in the remainder of fiscal 2023, approximately 45.8 % in fiscal 2024, and approximately 7.5 % in fiscal 2025 and thereafter. The foregoing excludes the value of other remaining performance obligations as they have original durations of one year or less, and also excludes information about variable consideration allocated entirely to a wholly unsatisfied performance obligation.
Contract balances: The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable is recorded at the invoiced amount, net of an allowance for credit losses. A receivable is recognized in the period we deliver goods or provide services or when our right to consideration is unconditional. A contract asset is recorded when we have performed under the contract but our right to consideration is conditional on something other than the passage of time. Contract assets as of July 1, 2023 and December 31, 2022 were $ 4.1 million and $ 1.9 million, respectively, and are reported on the Condensed Consolidated Balance Sheets as a component of Prepaid expenses and other current assets.
Contract liabilities include payments received and payments due in advance of performance under a contract and are satisfied as the associated revenue is recognized. Contract liabilities are reported on the Condensed Consolidated Balance Sheets at the end of each reporting period as a component of Deferred revenue and Other liabilities. Contract liabilities as of July 1, 2023 and December 31, 2022 were $ 21.0 million and $ 30.9 million, respectively. During the six months ended July 1, 2023, we recognized $ 21.5 million of revenue that was included in contract liabilities as of December 31, 2022.
Costs to obtain a contract: We generally expense sales commissions when incurred as a component of Selling, general and administrative expense, as the amortization period is typically less than one year.
Revenue by category: Refer to Note 16, Operating Segments and Enterprise-Wide Information , for further details.
Note 16 — Operating Segments and Enterprise-Wide Information
Our chief operating decision maker (“CODM”) is our Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company. We operate in two reportable segments consisting
19
of the Probe Cards segment and the Systems segment. The following table summarizes the operating results by reportable segment (dollars in thousands):
Three Months Ended
July 1, 2023 June 25, 2022
Probe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other Total
Revenues $ 115,303 $ 40,613 $ — $ 155,916 $ 167,708 $ 36,199 $ — $ 203,907
Gross profit 42,112 21,124 ( 2,953 ) 60,283 78,420 18,276 ( 2,327 ) 94,369
Gross margin 36.5 % 52.0 % 38.7 % 46.8 % 50.5 % 46.3 %
Six Months Ended
July 1, 2023 June 25, 2022
Probe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other Total
Revenues $ 242,631 $ 80,733 $ — $ 323,364 $ 327,691 $ 73,390 $ — $ 401,081
Gross profit 85,735 41,870 ( 6,244 ) 121,361 155,622 37,683 ( 4,712 ) 188,593
Gross margin 35.3 % 51.9 % 37.5 % 47.5 % 51.3 % 47.0 %
Operating results provide useful information to our management for assessment of our performance and results of operations. Certain components of our operating results are utilized to determine executive compensation along with other measures.
Corporate and Other includes unallocated expenses relating to amortization of intangible assets, inventory and fixed asset fair value adjustments due to acquisitions, share-based compensation, and restructuring charges which are not used in evaluating the results of, or in allocating resources to, our reportable segments.
Certain revenue category information by reportable segment was as follows (in thousands):
Three Months Ended
July 1, 2023 June 25, 2022
Probe Cards Systems Total Probe Cards Systems Total
Market:
Foundry & Logic $ 81,967 $ — $ 81,967 $ 122,380 $ — $ 122,380
DRAM 30,464 — 30,464 36,843 — 36,843
Flash 2,872 — 2,872 8,485 — 8,485
Systems — 40,613 40,613 — 36,199 36,199
Total $ 115,303 $ 40,613 $ 155,916 $ 167,708 $ 36,199 $ 203,907
Timing of revenue recognition:
Products transferred at a point in time $ 112,985 $ 40,040 $ 153,025 $ 166,701 $ 33,081 $ 199,782
Products and services transferred over time 2,318 573 2,891 1,007 3,118 4,125
Total $ 115,303 $ 40,613 $ 155,916 $ 167,708 $ 36,199 $ 203,907
Geographical region:
United States $ 31,131 $ 11,542 $ 42,673 $ 21,539 $ 9,703 $ 31,242
Taiwan 25,316 4,196 29,512 45,188 4,832 50,020
South Korea 26,455 1,408 27,863 27,418 1,337 28,755
China 16,516 6,992 23,508 40,578 9,157 49,735
Europe 2,415 8,401 10,816 3,824 4,267 8,091
Japan 3,902 4,030 7,932 6,716 3,221 9,937
Malaysia 6,177 500 6,677 16,157 87 16,244
Singapore 1,718 1,105 2,823 5,131 1,977 7,108
Rest of the world 1,673 2,439 4,112 1,157 1,618 2,775
Total $ 115,303 $ 40,613 $ 155,916 $ 167,708 $ 36,199 $ 203,907
20
Six Months Ended
July 1, 2023 June 25, 2022
Probe Cards Systems Total Probe Cards Systems Total
Market:
Foundry & Logic $ 183,529 $ — $ 183,529 $ 236,501 $ — $ 236,501
DRAM 50,354 — 50,354 71,280 — 71,280
Flash 8,748 — 8,748 19,910 — 19,910
Systems — 80,733 80,733 — 73,390 73,390
Total $ 242,631 $ 80,733 $ 323,364 $ 327,691 $ 73,390 $ 401,081
Timing of revenue recognition:
Products transferred at a point in time $ 236,903 $ 79,510 $ 316,413 $ 325,537 $ 68,497 $ 394,034
Products and services transferred over time 5,728 1,223 6,951 2,154 4,893 7,047
Total $ 242,631 $ 80,733 $ 323,364 $ 327,691 $ 73,390 $ 401,081
Geographical region:
United States $ 55,772 $ 24,632 $ 80,404 $ 41,515 $ 15,374 $ 56,889
Taiwan 64,213 5,628 69,841 87,710 15,379 103,089
China 34,992 15,615 50,607 73,369 14,765 88,134
South Korea 46,027 2,611 48,638 52,299 3,957 56,256
Europe 5,841 14,401 20,242 6,206 10,280 16,486
Japan 11,038 7,871 18,909 11,501 7,818 19,319
Malaysia 16,501 1,446 17,947 37,674 769 38,443
Singapore 4,918 3,245 8,163 15,415 2,589 18,004
Rest of the world 3,329 5,284 8,613 2,002 2,459 4,461
Total $ 242,631 $ 80,733 $ 323,364 $ 327,691 $ 73,390 $ 401,081
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.